These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 12004085)

  • 1. The molecular perspective: tamoxifen and the estrogen receptor.
    Goodsell DS
    Stem Cells; 2002; 20(3):267-8. PubMed ID: 12004085
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis, biochemical properties and molecular modelling studies of organometallic specific estrogen receptor modulators (SERMs), the ferrocifens and hydroxyferrocifens: evidence for an antiproliferative effect of hydroxyferrocifens on both hormone-dependent and hormone-independent breast cancer cell lines.
    Top S; Vessières A; Leclercq G; Quivy J; Tang J; Vaissermann J; Huché M; Jaouen G
    Chemistry; 2003 Nov; 9(21):5223-36. PubMed ID: 14613131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 2. Clinical considerations and new agents.
    Jordan VC
    J Med Chem; 2003 Mar; 46(7):1081-111. PubMed ID: 12646017
    [No Abstract]   [Full Text] [Related]  

  • 4. [Selective estrogen receptor modulators].
    Holzgrabe U
    Pharm Unserer Zeit; 2004; 33(5):357-9. PubMed ID: 15497329
    [No Abstract]   [Full Text] [Related]  

  • 5. Photodynamic cell-kill analysis of breast tumor cells with a tamoxifen-pyropheophorbide conjugate.
    Fernandez Gacio A; Fernandez-Marcos C; Swamy N; Dunn D; Ray R
    J Cell Biochem; 2006 Oct; 99(3):665-70. PubMed ID: 16795032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combinatorial chemistry in steroid receptor drug discovery.
    Flygare JA; Sutherlin DP; Brown SD
    Methods Mol Biol; 2001; 176():353-8. PubMed ID: 11554335
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiestrogens and selective estrogen receptor modulators as multifunctional medicines. 1. Receptor interactions.
    Jordan VC
    J Med Chem; 2003 Mar; 46(6):883-908. PubMed ID: 12620065
    [No Abstract]   [Full Text] [Related]  

  • 8. An expeditious synthesis of tamoxifen, a representative SERM (selective estrogen receptor modulator), via the three-component coupling reaction among aromatic aldehyde, cinnamyltrimethylsilane, and beta-chlorophenetole.
    Shiina I; Sano Y; Nakata K; Suzuki M; Yokoyama T; Sasaki A; Orikasa T; Miyamoto T; Ikekita M; Nagahara Y; Hasome Y
    Bioorg Med Chem; 2007 Dec; 15(24):7599-617. PubMed ID: 17904372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A molecular docking study of estrogenically active compounds with 1,2-diarylethane and 1,2-diarylethene pharmacophores.
    Kekenes-Huskey PM; Muegge I; von Rauch M; Gust R; Knapp EW
    Bioorg Med Chem; 2004 Dec; 12(24):6527-37. PubMed ID: 15556769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On-line formation, separation, and estrogen receptor affinity screening of cytochrome P450-derived metabolites of selective estrogen receptor modulators.
    van Liempd SM; Kool J; Niessen WM; van Elswijk DE; Irth H; Vermeulen NP
    Drug Metab Dispos; 2006 Sep; 34(9):1640-9. PubMed ID: 16790557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oestrogen receptors and selective oestrogen receptor modulators: molecular and cellular pharmacology.
    Nilsson S; Koehler KF
    Basic Clin Pharmacol Toxicol; 2005 Jan; 96(1):15-25. PubMed ID: 15667591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective estrogen-receptor modulators and antihormonal resistance in breast cancer.
    Jordan VC; O'Malley BW
    J Clin Oncol; 2007 Dec; 25(36):5815-24. PubMed ID: 17893378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Modern approaches to estrogen-independent growth of breast tumor].
    Krasil'nikov MA
    Vopr Onkol; 2004; 50(4):399-405. PubMed ID: 15605761
    [No Abstract]   [Full Text] [Related]  

  • 14. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance.
    Lewis JS; Jordan VC
    Mutat Res; 2005 Dec; 591(1-2):247-63. PubMed ID: 16083919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Selective estrogen receptor modulators: mechanisms of action and their tissue selectivity].
    Azuma K; Inoue S
    Clin Calcium; 2004 Oct; 14(10):12-26. PubMed ID: 15577127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. QSAR of estrogen receptor modulators: exploring selectivity requirements for ER(alpha) versus ER(beta) binding of tetrahydroisoquinoline derivatives using E-state and physicochemical parameters.
    Mukherjee S; Saha A; Roy K
    Bioorg Med Chem Lett; 2005 Feb; 15(4):957-61. PubMed ID: 15686893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor ligands. II. Discovery of benzoxathiins as potent, selective estrogen receptor alpha modulators.
    Kim S; Wu JY; Birzin ET; Frisch K; Chan W; Pai LY; Yang YT; Mosley RT; Fitzgerald PM; Sharma N; Dahllund J; Thorsell AG; DiNinno F; Rohrer SP; Schaeffer JM; Hammond ML
    J Med Chem; 2004 Apr; 47(9):2171-5. PubMed ID: 15084115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Molecular mechanisms of resistance to tamoxifen].
    Berstein LM; Santen RJ
    Vopr Onkol; 2002; 48(1):17-23. PubMed ID: 12101560
    [No Abstract]   [Full Text] [Related]  

  • 19. Simple and efficient production of (Z)-4-hydroxytamoxifen, a potent estrogen receptor modulator.
    Yu DD; Forman BM
    J Org Chem; 2003 Nov; 68(24):9489-91. PubMed ID: 14629178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Response to tamoxifen in estrogen receptor-positive cell line MCF-7 is independent of p53 expression].
    Shtam TA; Pantina RA; Varfolomeeva EIu; Filatov MV
    Vopr Onkol; 2007; 53(2):194-9. PubMed ID: 17663174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.